Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MICROCHIP TECHNOLOGY INC insiders sold a net $12.1M of stock across 82 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
25 earlier Form 4 trades (code P or S) here by this insider (25 sales), the last on Aug 17, 2026.
The trade is 14.4% of the 28,573 shares held after it.
No other insider sold within 30 days.
685 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SENIOR CORPORATE VP AND CFO Bjornholt James Eric sold about $309.7K of MCHP under a 10b5-1 plan on Aug 25, 2026; 685 funds added in the latest 13F quarter.
24 earlier Form 4 trades (code P or S) here by this insider (24 sales), the last on May 22, 2026.
The trade is 2.7% of the 30,960 shares held after it.
No other insider sold within 30 days.
685 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SENIOR CORPORATE VP AND CFO Bjornholt James Eric sold about $67.2K of MCHP on Aug 17, 2026; 685 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on May 22, 2026.
The trade is 3.8% of the 130,508 shares held after it.
3 other insiders sold within 30 days.
685 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF OPERATING OFFICER Simoncic Richard J sold about $487.6K of MCHP on Jun 4, 2026; 3 other insiders sold within 30 days and 685 funds added in the latest 13F quarter.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on May 15, 2026.
The trade is 17.0% of the 17,665 shares held after it.
4 other insiders sold within 30 days.
685 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director CHAPMAN MATTHEW W sold about $292.6K of MCHP on May 28, 2026; 4 other insiders sold within 30 days and 685 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 15, 2026.
The trade is 3.7% of the 135,508 shares held after it.
4 other insiders sold within 30 days.
685 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF OPERATING OFFICER Simoncic Richard J sold about $467.2K of MCHP on May 22, 2026; 4 other insiders sold within 30 days and 685 funds added in the latest 13F quarter.
82 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MCHP planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Bjornholt James Eric
Filed 2026-08-25
$309.7K
MCHP mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Quantified Common Ground Fund
$6.7M position · as of 2026-06-30
5.6%
FAM DIVIDEND FOCUS FUND
$32.5M position · as of 2026-06-30
5.1%
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
$2.1M position · as of 2026-05-31
4.7%
Muhlenkamp Fund
$10.9M position · as of 2026-06-30
4.2%
First Trust S&P 500 Diversified Dividend Aristocrats ETF
$2.2M position · as of 2026-06-30
3.6%
Advent Convertible Bond ETF
$1.1M position · as of 2026-05-31
3.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $12.1M sold by insiders over 180 days, 685 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $309.7K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MCHP
FY Mar 2026
$4.7B
FY Mar 2025
$4.4B
FY Mar 2024
$7.6B
FY Mar 2023
$8.4B
FY Mar 2022
$6.8B
Jun 2026
$1.5B
Mar 2026
$1.3B
Dec 2025
$1.2B
Sep 2025
$1.1B
Jun 2025
$1.1B
Mar 2025
$970.5M
Dec 2024
$1.0B
Sep 2024
$1.2B
At each fiscal year end
Single quarter
Net margin, TTM
+9.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MCHP
FY Mar 2026
+4.9%
FY Mar 2025
-0.0%
FY Mar 2024
+25.0%
FY Mar 2023
+26.5%
FY Mar 2022
+18.8%
Jun 2026
+15.5%
Mar 2026
+11.0%
Dec 2025
+5.3%
Sep 2025
+3.7%
Jun 2025
-1.7%
Mar 2025
-15.9%
Dec 2024
-5.2%
Sep 2024
+6.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.1B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MCHP
FY Mar 2026
$871.0M
FY Mar 2025
$772.1M
FY Mar 2024
$2.6B
FY Mar 2023
$3.1B
FY Mar 2022
$2.5B
Jun 2026
$497.6M
Mar 2026
$242.8M
Dec 2025
$318.9M
Sep 2025
$51.6M
Jun 2025
$257.7M
Mar 2025
$191.7M
Dec 2024
$253.4M
Sep 2024
$22.8M
At each fiscal year end
Single quarter
Debt to equity
0.83x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity MCHP
FY Mar 2026
0.85x
FY Mar 2025
0.80x
FY Mar 2024
0.90x
FY Mar 2023
0.99x
FY Mar 2022
1.30x
Jun 2026
0.83x
Mar 2026
0.85x
Dec 2025
0.82x
Sep 2025
0.80x
Jun 2025
0.80x
Mar 2025
0.80x
Dec 2024
1.12x
Sep 2024
1.02x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.22x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt MCHP
FY Mar 2026
0.18x
FY Mar 2025
0.16x
FY Mar 2024
0.48x
FY Mar 2023
0.56x
FY Mar 2022
0.37x
Jun 2026
0.22x
Mar 2026
0.18x
Dec 2025
0.17x
Sep 2025
0.16x
Jun 2025
0.15x
Mar 2025
0.16x
Dec 2024
0.17x
Sep 2024
0.27x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MCHP
FY Mar 2026
+3.4%
FY Mar 2025
-0.0%
FY Mar 2024
+29.0%
FY Mar 2023
+36.1%
FY Mar 2022
+22.9%
Jun 2026
+7.2%
Mar 2026
+3.4%
Dec 2025
-1.1%
Sep 2025
-2.9%
Jun 2025
-2.2%
Mar 2025
-0.0%
Dec 2024
+4.7%
Sep 2024
+11.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MCHP
FY Mar 2026
+1.5%
FY Mar 2025
-0.0%
FY Mar 2024
+11.8%
FY Mar 2023
+13.7%
FY Mar 2022
+7.9%
Jun 2026
+3.3%
Mar 2026
+1.5%
Dec 2025
-0.5%
Sep 2025
-1.2%
Jun 2025
-1.0%
Mar 2025
-0.0%
Dec 2024
+1.9%
Sep 2024
+4.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+5.7%
operating income after a 17.4% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital MCHP
FY Mar 2026
+3.5%
FY Mar 2025
n/a
FY Mar 2024
+16.8%
FY Mar 2023
+19.4%
FY Mar 2022
+12.3%
Jun 2026
+5.7%
Mar 2026
+3.5%
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+3.8%
Sep 2024
+7.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+5.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MCHP
FY Mar 2026
+3.6%
FY Mar 2025
+2.1%
FY Mar 2024
+19.3%
FY Mar 2023
+22.2%
FY Mar 2022
+12.8%
Jun 2026
+5.9%
Mar 2026
+3.6%
Dec 2025
+1.3%
Sep 2025
+0.4%
Jun 2025
+0.8%
Mar 2025
+2.1%
Dec 2024
+4.8%
Sep 2024
+9.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
111.62x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MCHP
FY Mar 2026
293.68x
FY Mar 2025
n/a
FY Mar 2024
25.78x
FY Mar 2023
20.89x
FY Mar 2022
33.10x
Jun 2026
134.12x
Mar 2026
293.68x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
100.61x
Sep 2024
55.76x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$46.3B
market value at close 2026-10-26 on 2026-07-28 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value MCHP
FY Mar 2026
$40.2B
FY Mar 2025
$30.9B
FY Mar 2024
$54.2B
FY Mar 2023
$52.1B
FY Mar 2022
$49.1B
Jun 2026
$54.5B
Mar 2026
$40.2B
Dec 2025
$39.6B
Sep 2025
$39.8B
Jun 2025
$42.8B
Mar 2025
$30.9B
Dec 2024
$37.0B
Sep 2024
$49.2B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield MCHP
FY Mar 2026
+2.5%
FY Mar 2025
+3.0%
FY Mar 2024
+5.4%
FY Mar 2023
+6.8%
FY Mar 2022
+5.9%
Jun 2026
+2.2%
Mar 2026
+2.5%
Dec 2025
+2.4%
Sep 2025
+2.2%
Jun 2025
+1.9%
Mar 2025
+3.0%
Dec 2024
+3.2%
Sep 2024
+3.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing MCHP
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
0.27x
FY Mar 2022
0.22x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MCHP ranks highest on institutional and government (59th percentile) and profitability (47th), and lowest on insider conviction (17th), among Semiconductors & Electronics peers.
Profitability
47
Inputs
Return on equity+7.2% · 58 pct, sector of 154
Return on assets+3.3% · 58 pct, sector of 171
Return on invested capital+5.7% · 16 pct, sector of 56
Return on capital employed+5.9% · 58 pct, sector of 155
Financial health
38
Inputs
Debt to equity0.83x · 23 pct, sector of 152
Cash flow to debt0.22x · 53 pct, sector of 136
Growth
44
Inputs
Revenue growth, YoY+7.1% · 44 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
17
Inputs
Net Form 4 buying (codes P and S), 180d-$11.8M · 34 pct, sector of 146
Insider buyers, 180d0 · 0 pct, sector of 150
Institutional and government
59
Inputs
Funds adding, latest quarter685 · 92 pct, sector of 184
Congress net buyers, 365d0 · 26 pct, sector of 40
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
24
Inputs
Short interest, % of float+5.9% · 47 pct, sector of 220
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.21 per $1B · 8 pct, universe of 1,049
New text in Risk Factors, latest 10-K+23.7% · 18 pct, sector of 152
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MCHP filings, in plain words
Are Microchip Technology insiders buying or selling MCHP?
In the 180 days to 2026-10-28, Microchip Technology insiders were net sellers, a net $12.1M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded MCHP?
Yes. In the year to 2026-10-28, 1 House member disclosed buying MCHP and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-09-16.
Are there planned insider sales of MCHP?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $309.7K of stock; the latest, by Bjornholt James Eric, was filed 2026-08-25.
Read the full summary
In the 180 days to 2026-10-28, Microchip Technology insiders were net sellers of MCHP, a net $12.1M across purchases and sales reported on Form 4 by 5 sellers. 8% of the 12 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 1 member of Congress disclosed buying MCHP and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-09-16. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $309.7K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.